India Pharma Outlook Team | Thursday, 01 October 2026
India powers primary care with an extraordinary scale of early detection.
Union Health Minister J.P. Nadda announces that more than 420 million screenings for hypertension and 420 million for diabetes have already taken place.
The nationwide network of Ayushman Arogya Mandirs has also completed 360 million oral cancer screenings, 170 million breast cancer screenings, and 90 million cervical cancer screenings.
These 1.86 lakh centers now stand as the backbone of population-based screening for people aged 30 and above.
The numbers reveal both a focused push for women’s cancer equity and a striking level of last-mile productivity that few primary-care systems worldwide can match.
This achievement turns routine neighborhood facilities into powerful engines of preventive health.
The program delivers one of the largest gender-specific health interventions in the world through ordinary primary-care centers.
This approach treats women’s health as an integral part of primary care instead of a parallel vertical, giving millions of women earlier detection and a clearer path to treatment.
Also Read: India's Pharma Independence: Powering Aatmanirbhar Bharat in Healthcare
Roughly 1.86 lakh Ayushman Arogya Mandirs have absorbed and delivered hundreds of millions of screenings while continuing their regular services.
The numbers show that India’s primary-care network has developed the organizational capacity to handle large-scale preventive work without collapsing under the load. Nadda underscores that screening for non-communicable diseases forms a core pillar of preventive healthcare.
The National Health Policy 2017 shift towards a balanced system of primary, secondary and tertiary care finds concrete expression in these Mandirs. They bring comprehensive primary healthcare closer to communities and create stronger linkages across levels of care.
India’s 1.86 lakh Ayushman Arogya Mandirs have turned primary care into a high-volume screening machine that simultaneously advances women’s health equity and demonstrates remarkable operational efficiency.
The 260 million breast and cervical cancer screening stand out as a deliberate, large-scale investment in women who historically face delayed diagnosis.
At the same time, the overall volume of more than a billion cumulative checks proves that last-mile centers can deliver population-level impact when policy, infrastructure, and frontline workers align.
These results strengthen the case for continued expansion of preventive services at the primary level and offer a practical model for other nations seeking to catch non-communicable diseases early.